Pseudolaric Acid B Suppresses T Lymphocyte Activation Through Inhibition of NF-κB Signaling Pathway and p38 Phosphorylation

被引:34
作者
Li, Ting [1 ]
Wong, Vincent Kam Wai [1 ]
Yi, Xiao Qin [1 ]
Wong, Yuen Fan [1 ]
Zhou, Hua [1 ]
Liu, Liang [1 ]
机构
[1] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon, Hong Kong, Peoples R China
关键词
PSEUDOLARIC ACID B; T LYMPHOCYTE ACTIVATION; CD25; NF-kappa B; P38; CELL-ACTIVATION; PROTEIN-KINASE; IMMUNE-RESPONSE; DIFFERENTIAL REGULATION; IL-2; PRODUCTION; NUCLEAR-FACTOR; EXPRESSION; PROLIFERATION; COSTIMULATION; TRANSDUCTION;
D O I
10.1002/jcb.22230
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pseudolaric acid B (PAB) is a major bioactive component of the medicinal plant Pseudolarix kaempferi. Traditional medicine practitioners in Asia have been using the roots of this plant to treat inflammatory and microbial skin diseases for centuries. In the current study, in vitro immunosuppressive effect of PAB and the underlying mechanisms have been investigated. The results showed that PAB dose-dependently suppressed human T lymphocyte proliferation, IL-2 production and CD25 expression induced by co-stimulation of PMA plus ionomycin or of anti-OKT-3 plus anti-CD28. Mechanistic studies showed that PAB significantly inhibited nuclear translocation of NF-kappa B p65 and phosphorylation and degradation of I kappa B-alpha evoked by co-stimulation of PMA plus ionomycin. PAB could also suppress the phosphorylation of p38 in the MAPKs pathway. Based on these evidences, we conclude that PAB suppressed T lymphocyte activation through inhibition of NF-kappa B and p38 signaling pathways; this would make PAB a strong candidate for further study as an anti-inflammatory agent. J. Cell. Biochem. 108: 87-95, 2009. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:87 / 95
页数:9
相关论文
共 40 条
[1]  
Calixto JB, 2004, PLANTA MED, V70, P93, DOI [10.1055/s-2004-815483, 10.1055/s-2003-45141]
[2]   CCR5 Expression Levels Influence NFAT Translocation, IL-2 Production, and Subsequent Signaling Events during T Lymphocyte Activation [J].
Camargo, Jose F. ;
Quinones, Marlon P. ;
Mummidi, Srinivas ;
Srinivas, Sowmya ;
Gaitan, Alvaro A. ;
Begum, Kazi ;
Jimenez, Fabio ;
VanCompernolle, Scott ;
Unutmaz, Derya ;
Ahuja, Seema S. ;
Ahuja, Sunil K. .
JOURNAL OF IMMUNOLOGY, 2009, 182 (01) :171-182
[3]  
Caruso A, 1997, CYTOMETRY, V27, P71, DOI 10.1002/(SICI)1097-0320(19970101)27:1<71::AID-CYTO9>3.0.CO
[4]  
2-O
[5]   Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation [J].
Diehn, M ;
Alizadeh, AA ;
Rando, OJ ;
Liu, CL ;
Stankunas, K ;
Botstein, D ;
Crabtree, GR ;
Brown, PO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11796-11801
[6]   MAP kinases in the immune response [J].
Dong, C ;
Davis, RJ ;
Flavell, RA .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :55-72
[7]   Diverse agents act at multiple levels to inhibit the Rel/NF-κB signal transduction pathway [J].
Epinat, JC ;
Gilmore, TD .
ONCOGENE, 1999, 18 (49) :6896-6909
[8]  
GATELY MK, 1991, J IMMUNOL, V147, P874
[9]   USE OF MTT COLORIMETRIC ASSAY TO MEASURE CELL ACTIVATION [J].
GERLIER, D ;
THOMASSET, N .
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 94 (1-2) :57-63
[10]   Simvastatin inhibits T-cell activation by selectively impairing the function of Ras superfamily GTPases [J].
Ghittoni, R ;
Patrussi, L ;
Pirozzi, K ;
Pellegrini, M ;
Lazzerini, PE ;
Capecchi, PL ;
Pasini, FL ;
Baldari, CT .
FASEB JOURNAL, 2005, 19 (01) :605-+